Posted: Tuesday, May 12, 2020
Ehab L. Atallah, MD, of the Medical College of Wisconsin, discusses maintenance therapy for patients with acute myeloid leukemia and whether it is safe, during the COVID-19 pandemic, to omit or reduce such treatments in this patient population.